Novavax Inc. (NVAX)
NASDAQ: NVAX
· Real-Time Price · USD
7.79
0.39 (5.27%)
At close: Sep 04, 2025, 3:59 PM
7.80
0.13%
Pre-market: Sep 05, 2025, 06:24 AM EDT
5.27% (1D)
| Bid | 7.73 |
| Market Cap | 1.27B |
| Revenue (ttm) | 1.08B |
| Net Income (ttm) | 422.82M |
| EPS (ttm) | 2.22 |
| PE Ratio (ttm) | 3.51 |
| Forward PE | -82.22 |
| Analyst | Hold |
| Ask | 7.83 |
| Volume | 7,260,451 |
| Avg. Volume (20D) | 6,532,212 |
| Open | 7.40 |
| Previous Close | 7.40 |
| Day's Range | 7.23 - 7.82 |
| 52-Week Range | 5.01 - 15.22 |
| Beta | 2.50 |
About NVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Novavax Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-4.08%
Shares of vaccine companies are trading lower foll...
Unlock content with
Pro Subscription
2 weeks ago
-12.7%
Novavax shares are trading lower after the company announced it has extended its $225 million convertible notes deal. Additionally, B of A Securities downgraded the stock yesterday from Neutral to Underperform and cut its price target from $9 to $7,
1 month ago · fool.com
Novavax (NVAX) Profit Jumps on MilestoneNovavax (NVAX) Profit Jumps on Milestone
